Table 4.
Effect of NLC-1, ATC suspension and Lipitor® tablet on serum level of total cholesterol, triglyceride, high-density lipoprotein and low-density lipoprotein.
| Group | TC (mg/dl) | TG(mg/dl) | LDL(mg/dl) | HDL (mg/dl) |
|---|---|---|---|---|
| I (negative control) | 50.8 ± 6.87 | 73 ± 5.24 | 12.87 ± 8.64 | 33.26 ± 6.93 |
| II (positive control) | 98.5 ± 2.67 | 178 ± 9.14 | 86.8 ± 6.48 | 29.09 ± 5.98 |
| III (atorvastatin suspension) | 59.45 ± 4.34a | 123.73 ± 5.11a | 48.37 ± 6.4a | 31.39 ± 2.95 |
| IV (NLC-1) | 45.94 ± 3.76a | 99 ± 4.67a | 23.16 ± 3.97a | 37.84 ± 1.79 |
| V (Lipitor®) | 54.7 ± 6.17a | 115.85 ± 7.49a | 38.63 ± 9.43a | 33.34 ± 4.68 |
Each value expressed as the mean ± SD (n = 3).
a
Significant at p < .05 as compared to positive control group.